VR Logo

EyePoint Pharmaceuticals Inc. (EYPT) download report


Healthcare | Biotechnology & Pharma Research

EyePoint Pharmaceuticals Inc. (EYPT) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom.

IPO Date: 27-Jan-2005

Pres, CEO & Director: Ms. Nancy S. Lurker

Chief Financial Officer: Mr. George O. Elston

Listing: NASDAQ: EYPT

Country: United States

Headquarters: Watertown, MA

Website: https://eyepointpharma.com

Key Facts

Market cap: $246.84 Mln

Revenue (TTM): $38.91 Mln

Earnings (TTM): $-67.11 Mln

Cash: $190.78 Mln

Total Debt: $41.28 Mln

Insider's Holding: 11.71%

Liquidity: Low

52 Week range: $7.00 - 21.50

Shares outstanding: 34,047,100

10 Years Aggregate:

  • CFO: $-198.06 Mln
  • EBITDA: $-262.46 Mln
  • Net Profit: $-297.55 Mln

Stock Performance

Time Period EyePoint Pharmaceuticals (EYPT) S&P BSE Sensex S&P Small-Cap 600
YTD-40.77-9.49-17.79
1 month-24.79-2.87-2.72
3 months-44.02-8.59-12.17
1 Year-24.480.81-15.82
3 Years-23.9810.397.14
5 Years-17.6111.116.20
10 Years-9.1412.0010.33
As on 24-Jun-2022
Year EyePoint Pharmaceuticals (EYPT) S&P Small-Cap 600 S&P BSE Sensex
202186.0225.2721.99
2020-57.559.5715.75
2019-17.9920.8614.38
201874.47-9.705.87
2017-36.8411.7327.91
2016-64.5224.741.95
201517.27-3.36-5.03